These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 49088)

  • 1. Immunochemistry of the thrombin-altered NH2-terminal disulfide knot of human fibrinogen.
    Qureshi GD; Butler VP; Harfenist EJ; Canfield RE; Nossel HL
    Thromb Res; 1975 Apr; 6(4):357-74. PubMed ID: 49088
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoantigenic expressions engendered by plasmin cleavage of fibrinogen.
    Plow EF; Hougie C; Edgington TS
    J Immunol; 1971 Nov; 107(5):1496-500. PubMed ID: 4107365
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic properties of Aalpha chain of human fibrinogen.
    Lefvert AK; Kudryk B; Murano G; Blombäck B
    Eur J Biochem; 1974 Aug; 47(1):23-6. PubMed ID: 4140090
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen-fibrin related antigen pattern in human blood. Incomplete lysis of whole blood clots by urokinase.
    Jacobsen CD; Fry GL; Wu KK; Southers NJ
    Thromb Res; 1975 Apr; 6(4):327-36. PubMed ID: 1079637
    [No Abstract]   [Full Text] [Related]  

  • 6. The structure of the fibrinogen degradation products.
    Marder VJ; Budzynski AZ
    Prog Hemost Thromb; 1974; 2(0):141-74. PubMed ID: 4137300
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunochemical studies on human fibrinogen and its fragments. Cross-reactivity of NH2-terminal "Disulfide Knot" and related structures as determined by radioimmunoassay.
    Kudryk B; Reuterby J; Blombäck B
    Eur J Biochem; 1974 Jul; 46(1):141-7. PubMed ID: 4136797
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of human platelet aggregation by plasmin digests of human and bovine fibrinogen preparations: role of contaminating factor VIII-related material.
    Culasso DE; Donati MB; de Gaetano G; Vermylen J; Verstraete M
    Blood; 1974 Aug; 44(2):169-75. PubMed ID: 4277539
    [No Abstract]   [Full Text] [Related]  

  • 9. High molecular weight derivatives of human fibrinogen produced by plasmin. 3. Their NH2-terminal amino acids and comparison with the "NH2-terminal disulfide knot".
    Marder VJ; Budzyński AZ; James HL
    J Biol Chem; 1972 Aug; 247(15):4775-81. PubMed ID: 4262216
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic markers on fragment DD, a unique plasmic derivative of human crosslinked fibrin.
    Budzynski AZ; Marder VJ; Parker ME; Shames P; Brizuela BS; Olexa SA
    Blood; 1979 Oct; 54(4):794-804. PubMed ID: 157788
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation and characterization of a specific antibody population against human fibrinogen.
    Lau HK; Cheung M; Siu A
    Biochem Int; 1987 Sep; 15(3):561-9. PubMed ID: 2447894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive radioimmunoassay for collagen.
    Adelmann BC; Gentner GJ; Hopper K
    J Immunol Methods; 1973 Dec; 3(4):319-36. PubMed ID: 4591346
    [No Abstract]   [Full Text] [Related]  

  • 13. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 14. The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis.
    Mosesson MW; Finlayson JS; Galanakis DK
    J Biol Chem; 1973 Nov; 248(22):7913-29. PubMed ID: 4127218
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary structure of human fibrinogen and fibrin. II. Structural studies on NH2-terminal part of gamma chain.
    Blombäck B; Gröndahl NJ; Hessel B; Iwanaga S; Wallén P
    J Biol Chem; 1973 Aug; 248(16):5806-20. PubMed ID: 4198885
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioimmunoassay of a large cyanogen bromide peptide of the human fibrinogen A alpha-chain.
    Gollwitzer R; Timpl R; Hafter R; Graeff H
    Bibl Haematol; 1977; 44():114-6. PubMed ID: 570038
    [No Abstract]   [Full Text] [Related]  

  • 17. Reaction of plasmic degradation products of fibrinogen in the radioimmunoassay of human fibrinopeptide A.
    Budzynski AZ; Marder VJ; Sherry S
    Blood; 1975 Jun; 45(6):757-68. PubMed ID: 1168512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and purification of fibrinogen degradation products produced by plasmin: considerations on the structure of fibrinogen.
    Marder VJ
    Scand J Haematol Suppl; 1971; 13():21-36. PubMed ID: 4258202
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinopeptide A immunoreactivity in human plasma.
    Gerrits WB; Flier OT; van der Meer J
    Thromb Res; 1974 Aug; 5(2):197-212. PubMed ID: 4472115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.